a 2017 study found that a combination of chlorhexidine & silver-sulfadiazine (css) used to coat central venous catheters (cvc) reduces the rate of catheter-related bloodstream infections. however they also found that the efficacy of the css-cvc coating was progressively eroded by blood-flow, and that the antibacterial function was lost after 48 hours.